Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Goldstein

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Head & Neck|January 25, 2020
Fractionation scheme and treatment planning method for early glottic cancer in the United States: Economic impact of different medical decisionsAssaf Moore, Robert B Den, Aaron Popovtzer, et al.
The Annals of Thoracic Surgery|June 26, 2016
Successful Robotic Excision and Early Chemotherapy for Primary Cardiac LymphomaEmmanuel Moss, Daniel A Goldstein, Kyle T Bradley, et al.
Clinical Colorectal Cancer|November 7, 2015
Metastatic Colorectal Cancer: A Systematic Review of the Value of Current TherapiesDaniel A Goldstein, Simon B Zeichner, Catherine M Bartnik, et al.
Nature Medicine|October 6, 2022
Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global accessIan Hirsch, Daniel A Goldstein, Ian F Tannock, et al.
Breast Cancer (Tokyo, Japan)|November 27, 2024
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohortDaniela Katz, Ilan Feldhamer, Yael Wolff-Sagy, et al.
The Journal of Reproductive Medicine|March 31, 2007
Twinning and higher intake of dairy productsDaniel A Goldstein, David F Kowalczyk, John L Vicini, et al.
Clinical Pharmacology in Drug Development|December 24, 2021
Subcutaneous Atezolizumab: A Jab Without a BenefitCody J Peer, Sara M Zimmerman, William D Figg, et al.
European Urology|August 16, 2017
Cost Effectiveness of Nivolumab in Advanced Renal Cell CarcinomaMichal Sarfaty, Moshe Leshno, Noa Gordon, et al.
Cancer Treatment Reviews|December 2, 2015
Adjuvant therapy for pancreas cancer in an era of value based cancer careDaniel H Ahn, Terence M Williams, Daniel A Goldstein, et al.
Immunotherapy|March 20, 2020
Treatment beyond progression with immune checkpoint inhibitors in non-small-cell lung cancerDaniel Reinhorn, Oded Jacobi, Oded Icht, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Head & Neck|January 25, 2020
Fractionation scheme and treatment planning method for early glottic cancer in the United States: Economic impact of different medical decisionsAssaf Moore, Robert B Den, Aaron Popovtzer, et al.
The Annals of Thoracic Surgery|June 26, 2016
Successful Robotic Excision and Early Chemotherapy for Primary Cardiac LymphomaEmmanuel Moss, Daniel A Goldstein, Kyle T Bradley, et al.
Clinical Colorectal Cancer|November 7, 2015
Metastatic Colorectal Cancer: A Systematic Review of the Value of Current TherapiesDaniel A Goldstein, Simon B Zeichner, Catherine M Bartnik, et al.
Nature Medicine|October 6, 2022
Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global accessIan Hirsch, Daniel A Goldstein, Ian F Tannock, et al.
Breast Cancer (Tokyo, Japan)|November 27, 2024
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohortDaniela Katz, Ilan Feldhamer, Yael Wolff-Sagy, et al.
The Journal of Reproductive Medicine|March 31, 2007
Twinning and higher intake of dairy productsDaniel A Goldstein, David F Kowalczyk, John L Vicini, et al.
Clinical Pharmacology in Drug Development|December 24, 2021
Subcutaneous Atezolizumab: A Jab Without a BenefitCody J Peer, Sara M Zimmerman, William D Figg, et al.
European Urology|August 16, 2017
Cost Effectiveness of Nivolumab in Advanced Renal Cell CarcinomaMichal Sarfaty, Moshe Leshno, Noa Gordon, et al.
Cancer Treatment Reviews|December 2, 2015
Adjuvant therapy for pancreas cancer in an era of value based cancer careDaniel H Ahn, Terence M Williams, Daniel A Goldstein, et al.
Immunotherapy|March 20, 2020
Treatment beyond progression with immune checkpoint inhibitors in non-small-cell lung cancerDaniel Reinhorn, Oded Jacobi, Oded Icht, et al.
Pageof 14